2′-fucosyllactose
Commercial- Indications
- Infant nutrition
Company intelligence / Profile preview
Jennewein Biotechnologie GmbH
Rheinbreitbach, Rhineland-Palatinate, Germanynewfoodmagazine.com ↗
- Ownership
- Private
- Employees
- ~100
- Development stage
- Commercial
01
Overview
Jennewein Biotechnologie was a global leader in the industrial-scale production of human milk oligosaccharides using proprietary fermentation technology. Its products are used primarily as functional ingredients in premium infant formulas worldwide, with additional applications envisioned in pharmaceuticals and cosmetics. The company was acquired by Chr. Hansen Holding A/S in September 2020 to strengthen Chr. Hansen’s position within the high-growth HMO market segment.
- Therapeutic areas
- EndocrinologyInfectious Diseases
- Modalities
- Fermentation-derived oligosaccharides and monosaccharides
- Industry
- Non-Drug Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Jennewein Biotechnologie GmbH.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Jennewein Biotechnologie GmbH.